AGP Picks
View all

Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on November 19, 2026

Korro to Participate in Upcoming Investor Conferences
aTyr Pharma Presents Preclinical Data for NRP2-Targeting Antibody ATYR2810 at the Connective Tissue Oncology Society (CTOS) 2026 Annual Meeting
Remix Therapeutics Announces Updated Positive REM-422 Phase 1 Data in Adenoid Cystic Carcinoma at 2026 EORTC-NCI-AACR Symposium
Regeneron Highlights New Data Across Malignant and Classical Hematology Programs at American Society of Hematology (ASH)
Axsome Therapeutics to Participate in Upcoming Investor Conferences
Verano Celebrates Grand Opening of MÜV Tarpon Springs, the Company’s 89th Florida Location, 166th Nationwide
Opus Genetics Announces First Participant Dosed in Phase 1/2 Clinical Trial of OPGx-RDH12 Gene Therapy for Rare Inherited Childhood Blindness
J-Star Holding Expands Mitsubishi Chemical Partnership to Advance U.S. UAV Manufacturing and Domestic Carbon Fiber Supply Chain
Enable Injections and ARespo Biopharma Announce Strategic Partnership
Marker Therapeutics Awarded $16.2 Million CPRIT Grant to Advance MT-601 in Phase 2 APOLLO Study
ANI Pharmaceuticals to Present at Upcoming December Investor Conference
CDT Notes Sarborg’s Sale of Cryptocurrency Trading Agent
EBI Reaches Key Milestone with First Patient Enrolled in Phase III EasyBoost Trial of EA-230, a Potential First-in-Class Medicine to Accelerate Recovery After Cardiac Surgery
Zymeworks Announces Participation in Upcoming Investor Conferences
DeepHealth to Present Recent Clinical Evidence Demonstrating the Breadth and Impact of Its AI Portfolio at RSNA 2026
Codexis to Participate in Piper Sandler 38th Annual Healthcare Conference
A Race Against Blindness Brings Back “Miles, Magic & Mochas” Fundraiser for the Holiday Season
HUTCHMED Announces China NMPA Approval of SYVIK® (sovleplenib) for the Treatment of Primary Immune Thrombocytopenia and Warm Antibody Autoimmune Hemolytic Anemia
Arcera Life Sciences and Innogen Pharmaceuticals Sign Exclusive Licensing Agreement to Expand Access to Cardiometabolic Care Across International Markets
Asgard Therapeutics awarded €2.5m EIC Accelerator grant to advance lead program AT-108 toward the clinic

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Yemen Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.